← Leaderboards
Margaret A Wheatley
Drexel University
$3,730,118
Attributed
$4,975,827
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $634.7K · FY2006–21$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,975,827 · 4
By mechanism
R01$4,353,074 · 2
R21$355,000 · 1
P01$267,753 · 1
Top collaborators
- John Eisenbrey4 shared
Others in their field
Top investigators on “Ultrasonography”
- Lihong Wang · Texas A&M University System$34,273,770
- Elisa E Konofagou · Columbia University Health Sciences$30,086,996
- Susan Fera Assmann · New England Research Institutes, Inc.$27,762,151
- Katherine W Ferrara · Stanford University$25,561,021
- Robyn McClelland · University Of Washington$22,870,230
- Ronald Wapner · Columbia University Health Sciences$22,573,201
Research focus
UltrasonographySurfactantContrast MediaDrug Design /Synthesis /ProductionCaliberTumorMalignant NeoplasmsIn VivoIn VitroMicrobubblesCapillary BedResponseSolid NeoplasmBaseAttenuationNeoplasm MetastasisAnimalsNoninvasive DiagnosisLaboratory RabbitMicrocapsuleDrug Screening /EvaluationPressureCell Culture TechniquesClinical Translation
Grant awards (16)
Clinically Translatable Ultrasound-Sensitive Microbubble Approaches for Overcoming Tumor Hypoxia$628,845
R01 · FY2021 · EB
Clinically Translatable Ultrasound-Sensitive Microbubble Approaches for Overcoming Tumor Hypoxia$617,101
R01 · FY2020 · EB
Clinically Translatable Ultrasound-Sensitive Microbubble Approaches for Overcoming Tumor Hypoxia$610,786
R01 · FY2019 · EB
Clinically Translatable Ultrasound-Sensitive Microbubble Approaches for Overcoming Tumor Hypoxia$634,686
R01 · FY2018 · EB
Development and Characterization of a Novel Contrast Agent$261,164
R01 · FY2009 · HL · contact PI
Development and Characterization of a Novel Contrast Agent$256,476
R01 · FY2008 · HL · contact PI
Development and Characterization of a Novel Contrast Agent$256,995
R01 · FY2007 · HL · contact PI
Development and Characterization Novel Contrast Agent$327,008
R01 · FY2006 · HL · contact PI
DEVELOPMENT OF A NEW CLASS OF ULTRASOUND CONTRAST AGENTS$193,286
R01 · FY2004 · HL
Contrast Enhanced Ultrasound with Therapeutic Modality$177,500
R21 · FY2004 · CA
DEVELOPMENT OF A NEW CLASS OF ULTRASOUND CONTRAST AGENTS$187,655
R01 · FY2003 · HL
Contrast Enhanced Ultrasound with Therapeutic Modality$177,500
R21 · FY2003 · CA
DEVELOPMENT OF A NEW CLASS OF ULTRASOUND CONTRAST AGENTS$186,191
R01 · FY2002 · HL
DEVELOPMENT OF A NEW CLASS OF ULTRASOUND CONTRAST AGENTS$192,881
R01 · FY2001 · HL
DIAGNOSITIC ULTRASOUND CONTRAST AGENTS--DEVELOPMENT AND EVALUATION$0
P01 · FY2001 · CA
DIAGNOSITIC ULTRASOUND CONTRAST AGENTS--DEVELOPMENT AND EVALUATION$267,753
P01 · FY2000 · CA